We observed a trend for higher fibroblast TGFβ signature (F-TBRS36) in partially and epigenetically escaped samples, and that TGFβ receptor 2 (TGFBR2) had significantly higher expression in escaped cancer biopsies than nonescaped or partially escaped ones (Extended Data Fig. 7g,h). This evidence concerns the gene TGFB1 and cancer.